期刊文献+

^(18)F-FDG符合线路显像在结直肠癌诊断中的临床价值 被引量:2

Value of^(18)F-fluorodeoxyglucose coincidence circuit imaging in diagnosis of colorectal cancer
下载PDF
导出
摘要 目的探讨18F-2-氟-2-脱氧-D-葡萄糖(18F-FDG)符合线路显像在结直肠癌诊断中的价值及对临床分期的影响。方法对189例临床拟诊结直肠癌患者术前行18F-FDG符合线路显像,原发灶显像结果与术后病理对照,所见转移灶经病理或多种影像学检查及临床随访予以确诊。结果 18F-FDG符合线路显像诊断结直肠癌原发灶的灵敏度、特异度、准确率、阳性预测值和阴性预测值分别为95.9%、70.0%、93.1%、96.4%和66.7%。对远处脏器转移诊断的准确率高,改变12.2%患者的M分期。结论 18F-FDG符合线路显像在结直肠癌原发病灶诊断及术前M分期中有较高价值,可为临床治疗方案的制订提供参考。 Objective To evaluate the value of 18F-fluorodeoxyglucose(18F-FDG) coincidence circuit imaging in the diagnosis and staging of colorectal cancer. Methods A total of 189 patients with clinical suspicion of colorectal cancer were diagnosed by 18F-FDG coincidence circuit imaging. The results of the primary tumor were compared with the postoperative pathological findings. The imaging appearance of metastatic cancer was confirmed by pathological diagnosis, other imaging results or clinical follow-up. Results The sensitivity, specificity, accuracy, positive predictive value and negative predictive value of 18FFDG coincidence circuit imaging in the diagnosis of primary tumor was 95.9%,70.0%,93.1%,96.4% and 66.7%, respectively.18F-FDG coincidence circuit imaging had a good accuracy in detecting distant lesions, and modified metastasis staging in12.2% patients. Conclusion 18F-FDG coincidence circuit imaging is useful in the diagnosis, metastasis staging and treatment of colorectal cancer.
出处 《肿瘤影像学》 2013年第3期211-213,共3页 Oncoradiology
关键词 18F-2-氟-2-脱氧-D-葡萄糖 符合线路显像 结直肠癌 诊断 18F-fluorodeoxyglucose Coincidence circuit imaging Colorectal cancer Diagnosis
  • 相关文献

参考文献13

  • 1丁勇,田嘉禾,卫勃,徐白萱,邵明哲,姚树林,尹大一,张书文,刘雁翎.^(18)FDG-PET在直肠、结肠癌诊断中的价值初探[J].同位素,2006,19(3):146-149. 被引量:9
  • 2陆品相,范文阶.^(18)F-FDG PET扫描在结直肠癌中的临床应用价值[J].中国现代医学杂志,2005,15(15):2366-2367. 被引量:4
  • 3Kanae Miyake,Yuji Nakamoto,Kaori Togashi.Dual-time-point 18F-FDG PET/CT in patients with colorectal cancer: clinical value of early delayed scanning[J]. Annals of Nuclear Medicine . 2012 (6)
  • 4Gaia Grassetto,Maria Cristina Marzola,Annamaria Minicozzi,Adil Al-Nahhas,Domenico Rubello.F-18 FDG PET/CT in Rectal Carcinoma: Where Are We Now?[J]. Clinical Nuclear Medicine . 2011 (10)
  • 5A. Orlacchio,O. Schillaci,N. Fusco,P. Broccoli,M. Maurici,M. Yamgoue,R. Danieli,S. D’Urso,G. Simonetti.Role of PET/CT in the detection of liver metastases from colorectal cancer[J]. La radiologia medica . 2009 (4)
  • 6Max Lonneux.FDG-PET and PET/CT in Colorectal Cancer[J]. PET Clinics . 2008 (2)
  • 7Susan L. Gearhart MD,Deborah Frassica MD,Ron Rosen MD,Michael Choti MD,Richard Schulick MD,Richard Wahl MD.Improved Staging With Pretreatment Positron Emission Tomography/Computed Tomography in Low Rectal Cancer[J]. Annals of Surgical Oncology . 2006 (3)
  • 8Hideki Otsuka,Michael M. Graham,Akiko Kubo,Hiromu Nishitani.The effect of oral contrast on large bowel activity in FDG-PET/CT[J]. Annals of Nuclear Medicine . 2005 (2)
  • 9Yosh ioka T,Yamaguch i K,Kubota K,et al.Evaluation of18F-FDG PET in patients w ith advanced,m etastatic,or recurrent gas-tric cancer. JNuclM ed . 2003
  • 10Israel Ora,Yefremov Nikolay,Bar-Shalom Rachel,Kagana Olga,Frenkel Alex,Keidar Zohar,Fischer Doron.PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. Journal of nuclear medicine : official publication, Society of Nuclear Medicine . 2005

二级参考文献13

  • 1田嘉禾.临床正电子断层成像图谱[M].北京:中国协和医科大学出版社,2002.224-231.
  • 2ECKHART W, BIANCA B, ANDR EASH, et al.Positron Emission Tomogra-phy(PET) for Staging and Evaluation of Response to Treatment in Patients With Hodgkin's Disease[J]. Leukemia and Lymphoma, 1999, 34: 545.
  • 3ROHREN EM, TURKINGTON TG, COLEMAN RE. Clinical Applications of PET in Oncology[J].Radiology, 2004, 231(2):305-332.
  • 4STAHL A, OTT K, WEBER WA, et al. FDG PET Imaging of Locally Advanced Gastric Carcinomas: Correlation With Endoscopic and Histopathological Findings[J] . Eur J Nucl Med Mol Imaging,2003, 30(2): 288.
  • 5FRIEDLAND S, SOETIKNO R, CARIASI.E M,et al. 18-Fluorodeoxyglucose Positron Emission Tomography Has Limited Sensitivity for Colonic Adenoma and Early Stage Colon Cancer[J]. Gastrointest Endosc,2005, 61(3):395-400.
  • 6LARSON SM, SCHODER H, YEUNG H. Positron Emission" Tomography/Co-mputerized Tomography Functional Imaging of Esophageal and Colorectal Cancer [J]. Cancer, 2004, 10(4) : 243-250.
  • 7THALER K, KANNEGANTI S, KH-AJANCHE E Y, et al. The Evolving Role of Staging Laparoscopy in the Treatment of Colorectal Hepatic Metastasis[J]. Arch Surg, 2005, 140(8): 727-734.
  • 8ABDEI. NABI H,DOERR RJ, LAMONICA S, et al. Staging of Primary Colorectal Carcinomas With Fluorine-18-Fluorodeoxyglucose Whole-Body PET:Correlation With Histopathologic and CT Findings[J]. Radiology, 1998, 206:755-760.
  • 9ZUBELDIA JM, BEDNARCZYK EM, BAKER JG, et al. The Economic Impact of ^18FDG Positron Emission Tomography in the Surgical Management of Colorectal Cancer With Hepatic Metastases[J] .Cancer Biother Radiopharm, 2005, 20 (4):450-456.
  • 10SUSAN H, HENRY WDY, HOMER AM, et al.Whole-body FDG-PET in Patients With Recurrent Colorectal Carcinoma: a Comparative Study With CT[J].Clin Posit Imag, 2000, 3(3): 107-114.

共引文献11

同被引文献44

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部